Related Experiment Video
Updated: Feb 11, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Atrial fibrillation and hypertension: State of the art
Insights
Hypertension can lead to atrial fibrillation through cardiac structural changes. Managing blood pressure and treating atrial fibrillation are crucial for preventing complications like stroke and heart failure.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation and hypertension frequently coexist, increasing with age and contributing to significant morbidity and mortality.
- Hypertension-induced left ventricular hypertrophy and left atrial remodeling are key factors promoting atrial fibrillation development.
Purpose of the Study:
- To explore the intricate relationship between hypertension and atrial fibrillation.
- To highlight the impact of coexisting atrial fibrillation in hypertensive patients.
Main Methods:
- Review of clinical studies examining the association between hypertension and atrial fibrillation.
- Analysis of pathophysiological mechanisms linking cardiac structural changes to atrial fibrillation.
Main Results:
- Hypertension-induced cardiac remodeling predisposes individuals to atrial fibrillation.
- Atrial fibrillation in hypertensive patients elevates the risk of thromboembolic events and heart failure.
Conclusions:
- Pharmacological management of hypertension can mitigate cardiac structural changes, potentially preventing atrial fibrillation.
- Treatment for atrial fibrillation in hypertensive patients requires heart rate/rhythm control, thromboembolism prevention, and strict blood pressure management.
Abstract:
Atrial fibrillation and hypertension are often coexistent. Their incidence increases with advancing age and they are responsible for considerable morbidity and mortality. The relation between theses 2 diseases has long been discussed and determined by clinical studies. Left ventricular hypertrophy and left atrial remodeling during hypertension favor the development of atrial fibrillation. AF during hypertension increases the risk of thromboembolic complications and heart failure. In patients with hypertension, pharmacological treatment may control the cardiac structural changes and retard or prevent the occurrence of atrial fibrillation. In case of atrial fibrillation, treatment should be focused on the control of heart rate and rhythm and the prevention of thromboembolic accidents. A strict control of blood pressure is highly required in this situation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management

